Portrait of Darcey Dearden, Senior Sales Executive, Vālenz

Darcey Dearden Joins Vālenz as Senior Sales Executive

PHOENIX, Ariz. (February 24, 2020) – Vālenz™, a leading innovator for data-driven solutions that reduce medical claim costs and promote quality healthcare, welcomes Darcey Dearden as Senior Sales Executive. An award-winning sales professional for more than 20 years, Dearden has a proven record of consistently exceeding performance goals and building strong relationships with clients and referral partners.

Prior to joining Valenz, Dearden was Regional Vice President for Total Administrative Services Corporation, the nation’s largest privately held third-party benefits administrator. There, she elevated underperforming teams and established new standards to enhance accountability, collaboration and production. Her work experience also includes sales management positions at BenefitMall and Paychex.

“Darcey offers a winning combination of excellence in sales leadership, team building, and uncovering new solutions that maximize efficiency and reduce costs,” said Rob Gelb, Chief Executive Officer. “Her skill sets in strategic execution and effective communication make her well positioned to help our clients achieve smarter, better, faster healthcare. She is an outstanding fit for our team.”

Dearden brings to Valenz a strong background in business-to-business sales, benefit administration and compliance. She says she is thrilled to join Valenz because, as the innovators behind the industry’s first complete health administrative ecosystem, Valenz embodies the future-focused, client-centric, data-driven vision necessary for lower-cost, higher-quality healthcare.

“I look forward to meeting and exceeding our clients’ needs with the leading-edge data science and solutions that are unique to the Valenz ecosystem,” Dearden said. “I share this company’s dedication to managing costs and improving quality of care, and it is an honor to be part of such a vibrant, growing team.”

For more information, call 877-601-2200.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.

Portrait of Rob Gelb, Chief Executive Officer at Vālenz

Vālenz Appoints Rob Gelb as Chief Executive Officer

Key Leadership Moves Support Rapid Expansion of Industry’s First Health Administrative Ecosystem

PHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ today announced the appointment of Rob Gelb as Chief Executive Officer. Gelb, who joined the firm in 2018 as Chief Revenue Officer, succeeds Josh Carder as CEO, while Carder assumes a new position as Chairman of the Board.

“When Josh founded this company 17 years ago, he did so with a vision to solve the complex administrative challenges affecting healthcare costs – and that vision still drives us today,” said Gelb. “It is an honor to be selected as CEO to continue moving forward through the power of innovation and next-generation data integration.”

Since joining Valenz, Gelb has been instrumental in integrating key acquisitions that created the foundation for the company’s single-source solutions and data analytics platform, also known as the Valenz health administrative ecosystem. Throughout his 30+ year career, he has held leadership positions at several prestigious firms, including York (now Sedgwick), Coventry, CIGNA and others.

“Rob is a highly esteemed leader with a proven record of strategic and tactical success in creating and expanding healthy companies, and I am thrilled that he is now taking the reins as CEO of Valenz,” said Carder, adding that he is equally excited to become Chairman of the Board, where he can continue to influence the Valenz vision and promise of smarter, better, faster healthcare.

In addition to Gelb’s appointment, the board announced that Amy Gasbarro has been appointed Chief Operating Officer. Read more about Gasbarro’s appointment here.

About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.

Portrait of Amy Gasbarro, Chief Operating Officer at Vālenz

Vālenz Appoints Amy Gasbarro as Chief Operating Officer

PHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ has appointed Amy Gasbarro as Chief Operating Officer. Since 2018, Gasbarro has served as President of Vālenz Care, the firm’s care management solution.

“I commend the Board for their decision to appoint Amy to this role,” said Rob Gelb, the firm’s new Chief Executive Officer, adding that Gasbarro’s leadership background spans two decades at companies focused on population health and cost management solutions for self-funded employers. “Her expertise, combined with her shared vision for the future of Valenz, make her an excellent choice to oversee operations for the next high-growth phase of our company.”

In addition to her leadership role at Valenz, Gasbarro is actively involved in committees that advocate for self-insured employers, including the Government Relations Committee for the Self-Insurance Institute of America (SIIA) and the SIIA Political Action Committee. Such involvement ensures she has a seat at the table as a voice for self-funded groups, helping to steer public policy in support of favorable outcomes – namely, lower-cost, higher-quality healthcare.

Those outcomes are at the heart of everything they do at Valenz, says Gasbarro, where delivering on the company’s promise involves taking every opportunity to engage early and often for smarter, better, faster healthcare. As COO, Gasbarro is committed to supporting the Valenz team as the enterprise grows, and as its flagship platform – the industry’s first complete, end-to-end health administrative ecosystem – expands.

“Through the analytic and predictive power of the Valenz ecosystem, we are continuously broadening our ability to influence better health outcomes and reduce total cost of care,” said Gasbarro. “This is a very exciting time for Valenz, and I look forward to my new role in shaping a more prosperous future for our company, and more importantly, for our clients.”

About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.

2020 Year of the Nurse: Vālenz Celebrates the Impact of Nursing Excellence

As the innovators behind a new, data-driven ecosystem that reduces medical claim costs and promotes quality healthcare, Vālenz™ joins the World Health Organization in recognizing 2020 as the Year of the Nurse. Integral to Valenz’s services is its team of nurse case managers, who work closely with patients, providers, employers and payers to target the most appropriate levels of care before services are rendered, resulting in substantial savings for plans and members.

“Nurse case managers are essential to the Valenz promise of engaging early and often for smarter, better, faster healthcare,” said Amy Gasbarro, President of Vālenz Care, a triple-URAC accredited solution within the firm’s complete healthcare administrative ecosystem. “Their work improves quality and outcomes while also empowering our clients to move from reactive plan models to proactive population health management.”

For patients, nurse case managers are advocates for high-quality, lower-cost care – and many registered nurses on the Valenz team specialize in common and costly health conditions such as diabetes, cancer and pregnancy, among others. For self-insured employers and other professional stakeholders, nurse case managers help manage health administrative costs and quality by reducing expensive, unnecessary and/or preventable emergency room visits, hospitalizations, tests and other high-dollar claim events.

“Driven by actionable data — both individualized and aggregated — our Case Management solution ensures comprehensive care while minimizing out-of-pocket costs,” said Rob Gelb, Chief Revenue Officer of Valenz. “Our nurses serve as a central point of contact, guiding clients through treatment, so they can focus on what matters most — returning to good health.”

For all these reasons and more, says Gelb, Valenz is proud to celebrate the incredible impact of nursing excellence – this year and every year. For more information about Valenz Care, call (877) 601-2200.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.